https://doi.org/10.4081/monaldi.2018.961
Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation
Accepted: May 11, 2018
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Old age remains one of the strongest risk factors for stroke in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is the most effective way to prevent thromboembolic disease in patients with atrial fibrillation (AF). Until few years ago, aspirin and vitamin-K antagonists (VKAs) were the primary agents used to prevent thromboembolic disease in patients with AF. The approval of non–vitamin K oral anticoagulants (NOACs) has now expanded the range of therapeutic agents available to providers. The authors highlight practical considerations regarding the selection and use of OAC in older adults to aid clinical decision making.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Giampaolo Scorcu, Annarita Pilleri, Treatment of heart failure in the elderly: Which drugs are essential and which should be avoided , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Gian Francesco Mureddu, Arterial hypertension: which targets in over-75-year people? , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Athanassios Antonopoulos, Laila Fiorani , Ischemic stroke in a patient with interatrial block: Is it only a coincidence or a clear relationship? , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Francesco Vetta, Gabriella Locorotondo, Giampaolo Vetta, Maria Mignano, Sonia Bracchitta, Prognostic impact of frailty in elderly cardiac surgery patients , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Francesco Barillà , Concetta Torromeo, Riccardo Iorio, Luigina Porco, Vincenzo Paravati, Carlo Gaudio, Antiplatelet therapy in elderly patients with acute coronary syndrome: Between scientific evidence and future perspectives , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Stefania Angela Di Fusco, Nadia Aspromonte, Stefano Aquilani, Luca Mele, Furio Colivicchi, Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of Prothrombin Complex Concentrate , Monaldi Archives for Chest Disease: Vol. 80 No. 4 (2013): Cardiac Series
- Berardo Sarubbi, Gaetano Rea, Giuseppe Santoro, Enrico Melillo, Giancarlo Scognamiglio, Maria Giovannna Russo, Pulmonary veins stenosis relief after an inappropriate radiofrequency catheter ablation of atrial fibrillation in a young non-competitive athlete , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Gabriele Valli, Francesca De Marco, Maria Teresa Spina, Valentina Valeriano, Antonello Rosa, Valentina Minerva, Enrico Mirante, Maria Pia Ruggieri, Francesco Rocco Pugliese, A pilot study on the application of the current European guidelines for the management of acute coronary syndrome without elevation of ST segment (NSTEMI) in the Emergency Department setting in the Italian region Lazio , Monaldi Archives for Chest Disease: Vol. 82 No. 4 (2014): Cardiac series
- Gian Francesco Mureddu, Arterial hypertension. Does the J curve exist? And then? , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Alessandro Boccanelli, Pompilio Faggiano, Preoperative risk evaluation in patients over 75 years candidates to non-cardiac and cardiac surgery , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
